tiprankstipranks
Trending News
More News >
HOYA CORPORATION (JP:7741)
:7741

HOYA (7741) AI Stock Analysis

Compare
8 Followers

Top Page

JP:7741

HOYA

(7741)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 5.2)
Rating:74Outperform
Price Target:
¥28,974.00
▲(12.00% Upside)
HOYA's strong financial performance is the most significant factor, supported by robust profitability and financial stability. Technical analysis indicates a positive trend, though valuation concerns due to a high P/E ratio slightly offset the overall score. The absence of earnings call and corporate events data limits additional insights.
Positive Factors
High profit margins
Sustained very high gross and strong net margins indicate durable pricing power and an efficient cost base across HOYA's product mix. High margins support reinvestment in R&D, medical device development and premium lens innovation, underpinning long-term profitability and competitive positioning.
Very conservative balance sheet
Extremely low leverage and a high equity ratio provide financial flexibility to fund capex, acquisitions or downturns without straining cash flow. Strong ROE indicates efficient capital use, allowing HOYA to pursue strategic investments while maintaining resilience in stressed market conditions.
Strong free cash flow generation
Robust FCF growth and operating cash conversion above parity signal high-quality earnings and internal funding capacity. Reliable cash generation supports sustained investment in medical technologies, product development, shareholder returns, and balance-sheet strength over the medium term.
Negative Factors
Recent revenue growth softness
Single-digit revenue growth in the latest TTM suggests near-term top-line momentum is limited, reflecting market maturity or mix headwinds. Without stronger organic growth or inorganic initiatives, this can cap long-term upside and place greater emphasis on margin expansion to drive earnings.
Cyclicality in technology segment
Exposure to downstream electronics and industrial demand cycles creates structural revenue and margin volatility in the precision components business. This cyclical dependence can pressure cash flow and utilization during downturns, requiring diversification or counter-cyclical strategies to stabilize earnings.
Limited public disclosure/management visibility
Absence of earnings call and corporate-event disclosures in the provided data reduces visibility into management's strategic priorities, guidance and execution. For investors this increases governance and informational risk, making it harder to assess execution of long-term initiatives and operational risks.

HOYA (7741) vs. iShares MSCI Japan ETF (EWJ)

HOYA Business Overview & Revenue Model

Company DescriptionHOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and medical related products, such as prosthetic ceramic fillers and metallic implants. It also operates Eyecity, a specialty retailer of contact lenses. In addition, the company provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; photomasks for liquid crystal display panels; glass disks for hard disk drives; and imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources. Further, it offers ReadSpeaker, a speech synthesis software; and cloud services comprising Kinnosuke that is a time and attendance management service, and Yonosuke, an electronic payslip service. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyHOYA generates revenue through multiple key streams. The Healthcare segment contributes significantly by selling intraocular lenses and surgical instruments for cataract surgery, as well as a variety of eyeglass lenses and contact lenses. Revenue in this sector is bolstered by ongoing demand for vision correction products and an aging population. The Electronics segment generates income by supplying photomasks and other critical materials used in semiconductor fabrication, catering to major tech companies in the electronics industry. Strategic partnerships with leading semiconductor manufacturers and healthcare providers enhance HOYA's market presence and revenue opportunities. Additionally, the company invests in research and development to innovate and expand its product offerings, further driving growth and profitability.

HOYA Financial Statement Overview

Summary
HOYA demonstrates strong financial performance with high profitability, robust revenue growth, and efficient operations. The balance sheet shows low leverage and high return on equity, indicating financial stability. Cash flow metrics highlight strong cash generation, though there is room for improvement in cash conversion efficiency.
Income Statement
85
Very Positive
HOYA's income statement reflects strong profitability with a high gross profit margin of 80.12% and a solid net profit margin of 23.45% in the TTM period. The company has demonstrated consistent revenue growth, with a 2.27% increase in the latest TTM period. EBIT and EBITDA margins are robust at 30.65% and 36.45%, respectively, indicating efficient operational performance. The steady growth and high margins suggest a well-managed cost structure and strong market position.
Balance Sheet
80
Positive
HOYA's balance sheet is characterized by low leverage, with a debt-to-equity ratio of 0.041, indicating prudent financial management. The return on equity is strong at 21.07%, reflecting effective use of shareholder funds to generate profits. The equity ratio stands at 78.38%, showcasing a solid capital structure with a significant portion of assets financed by equity. Overall, the balance sheet reflects financial stability and low risk.
Cash Flow
78
Positive
The cash flow statement shows a healthy free cash flow growth rate of 82% in the TTM period, indicating strong cash generation capabilities. The operating cash flow to net income ratio is 1.28, suggesting efficient conversion of income into cash. The free cash flow to net income ratio of 0.79 further supports the company's ability to generate cash relative to its net income. These metrics highlight strong cash flow management, although there is room for improvement in cash conversion efficiency.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue892.50B866.03B762.61B723.58B661.47B547.92B
Gross Profit715.03B693.58B606.30B567.05B511.05B424.21B
EBITDA325.28B309.48B284.45B266.20B254.48B196.57B
Net Income209.28B202.10B181.38B168.64B164.51B125.45B
Balance Sheet
Total Assets1.28T1.23T1.20T1.03T992.84B853.29B
Cash, Cash Equivalents and Short-Term Investments596.39B533.97B525.16B405.89B419.40B334.90B
Total Debt41.54B37.28B29.24B24.58B21.60B20.75B
Total Liabilities280.48B262.65B241.36B213.72B203.78B180.88B
Stockholders Equity1.01T974.02B967.76B818.32B803.85B688.00B
Cash Flow
Free Cash Flow194.43B187.19B181.73B168.36B161.18B120.57B
Operating Cash Flow247.05B235.11B222.80B201.83B190.06B151.81B
Investing Cash Flow-15.10B-35.82B-35.81B-39.93B-29.13B-29.79B
Financing Cash Flow-202.51B-187.72B-110.89B-202.16B-106.89B-115.67B

HOYA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price25870.00
Price Trends
50DMA
24234.80
Positive
100DMA
23340.55
Positive
200DMA
20475.44
Positive
Market Momentum
MACD
364.56
Negative
RSI
64.02
Neutral
STOCH
54.29
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7741, the sentiment is Positive. The current price of 25870 is above the 20-day moving average (MA) of 25129.25, above the 50-day MA of 24234.80, and above the 200-day MA of 20475.44, indicating a bullish trend. The MACD of 364.56 indicates Negative momentum. The RSI at 64.02 is Neutral, neither overbought nor oversold. The STOCH value of 54.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7741.

HOYA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
¥8.73T35.2820.74%1.01%8.83%8.63%
68
Neutral
¥2.98T22.799.31%1.22%7.68%10.08%
68
Neutral
¥681.88B45.6410.09%0.82%13.53%-7.39%
68
Neutral
¥2.03T21.2013.13%1.01%0.42%34.76%
62
Neutral
¥231.60B21.274.38%2.03%6.04%733.13%
61
Neutral
¥914.83B19.599.80%1.88%1.51%-12.59%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7741
HOYA
25,870.00
6,492.01
33.50%
JP:4543
Terumo
2,017.50
-799.57
-28.38%
JP:7747
Asahi Intecc Co
2,570.00
42.66
1.69%
JP:8086
Nipro
1,420.00
20.35
1.45%
JP:7733
Olympus
1,841.00
-401.55
-17.91%
JP:6869
Sysmex
1,467.00
-1,381.28
-48.50%

HOYA Corporate Events

HOYA Delivers Strong Q3 Earnings and Lifts Full-Year Profit Outlook
Jan 30, 2026

HOYA reported a strong performance for the three months ended December 31, 2025, with revenue rising 10.8% year-on-year to ¥244.7 billion and profit before tax surging 69.9% to ¥110.8 billion, lifting the profit margin to 45.3%. Quarterly profit attributable to owners of the company jumped 81.4% to ¥91.6 billion, driving basic earnings per share up to ¥270.54, while total assets and equity both increased and the equity ratio edged up to 78.7%, underscoring a solid financial position. Operating cash flow improved to ¥64.3 billion and free cash flow expanded to ¥59.5 billion despite higher capital expenditure and R&D spending, indicating robust cash generation alongside continued investment. Reflecting this momentum, HOYA raised its full-year outlook for the year ending March 31, 2026, projecting revenue of ¥940 billion and a 25%-plus increase in profit attributable to owners, signaling confidence in sustained earnings growth and reinforcing its competitive standing for investors and other stakeholders.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen26000.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Highlights Assumptions and Risks Underpinning FY25 Q3 Outlook
Jan 30, 2026

In its FY25 third-quarter earnings presentation dated January 30, 2026, HOYA Corporation provided commentary that included forward-looking statements regarding its future plans and performance. These statements, based on management’s assumptions about macroeconomic conditions, market trends, competition, production capacity, financial metrics, regulatory and clinical outcomes, and broader risk factors such as pandemics, underscore the inherent uncertainty around HOYA’s outlook and highlight the range of external variables that could influence its operations and results.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen26000.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Launches ¥100 Billion Share Buyback Targeting 1.48% of Outstanding Stock
Jan 30, 2026

HOYA CORPORATION’s board has approved a share repurchase program aimed at enhancing shareholder returns, improving capital efficiency and maintaining a flexible capital policy. The company will buy back up to 5 million shares, representing about 1.48% of its outstanding shares (excluding treasury stock), for a maximum total of 100 billion yen through market purchases on the Tokyo Stock Exchange between February 2 and July 17, 2026, with the repurchased shares slated for cancellation, a move that is expected to reduce share count and potentially support earnings per share and shareholder value.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen26000.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA to Cancel 4.7 Million Treasury Shares to Boost Capital Efficiency
Dec 23, 2025

HOYA CORPORATION’s Board of Directors has approved the cancellation of 4,708,300 shares of its common stock, equivalent to 1.37% of shares outstanding, as part of a strategy to improve capital efficiency and enhance returns to shareholders by reducing the total number of shares in circulation. Following the cancellation, scheduled for January 9, 2026, the company will have 338,414,320 issued and outstanding shares, a move that is expected to support shareholder value by potentially increasing earnings per share and reinforcing HOYA’s shareholder-friendly capital allocation policy.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen26561.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Corporation Concludes Share Repurchase Plan
Dec 5, 2025

HOYA Corporation announced the completion and termination of its share repurchase plan, which was initially resolved by the Board of Directors on August 21, 2025. The company repurchased a total of 4,708,300 shares, amounting to approximately 99.999 billion yen, through market purchases on the Tokyo Stock Exchange, reflecting a strategic move to enhance shareholder value.

The most recent analyst rating on (JP:7741) stock is a Hold with a Yen24852.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Corporation Updates on Share Repurchase Program
Dec 1, 2025

HOYA Corporation announced the status of its ongoing share repurchase program, which was initially resolved by the Board of Directors in August 2025. As of November 30, 2025, the company has repurchased 4,650,000 shares, spending a total of 98,658,475,500 yen, with a maximum target of 6.2 million shares by January 2026. This strategic move is part of HOYA’s efforts to enhance shareholder value and optimize its capital structure.

The most recent analyst rating on (JP:7741) stock is a Hold with a Yen24852.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Corporation to Restructure Contact Lens Business
Nov 5, 2025

HOYA Corporation announced a strategic move to transfer its contact lens retail business to a newly formed subsidiary, HOYA Eye Care Retailing Corporation, effective April 1, 2026. This decision aims to enhance business operations by allowing for more focused sales, marketing, and store management strategies tailored to the contact lens industry, potentially improving market positioning and operational efficiency.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen30000.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Corporation Updates on Share Repurchase Progress
Nov 4, 2025

HOYA Corporation announced the status of its ongoing share repurchase plan, which was resolved by the Board of Directors in August 2025. As of October 31, 2025, the company repurchased 2,022,600 shares for approximately 44.56 billion yen, as part of a larger plan to buy back up to 6.2 million shares. This strategic move is likely to impact the company’s stock value and shareholder returns, reflecting HOYA’s commitment to enhancing shareholder value.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen30000.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Corporation Announces Significant Interim Dividend Increase
Oct 31, 2025

HOYA Corporation announced an interim dividend of 125 yen per share for the fiscal year ending March 31, 2026, marking a significant increase from the previous year’s interim dividend. This decision reflects HOYA’s strategy to enhance corporate value by balancing growth investments with shareholder returns, while maintaining financial soundness and capital efficiency.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen25911.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 11, 2025